Back To Top
Samsung Biologics to acquire Biogen’s stake in Samsung Bioepis for $2.3 billion
Samsung Biologics to acquire Biogen’s stake in Samsung Bioepis for $2.3 billion
IndustryJan 28, 2022
Buyout of Biogen’s stake expected to boost Samsung’s competitiveness in global bio industry